Late presentation of arrhythmogenic right ventricular cardiomyopathy in an octogenarian associated with a pathogenic variant in the plakophilin 2 gene: a case report

BMC Cardiovasc Disord. 2019 Feb 19;19(1):41. doi: 10.1186/s12872-019-1018-2.

Abstract

Background: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited myocardial disease characterized by fibrofatty replacement and ventricular arrhythmias. ARVC is believed to be a disease of the young, with most cases being diagnosed before the age of 40 years. We report here a case of newly diagnosed ARVC in an octogenarian associated with a pathogenic variant in the plakophilin 2 gene (PKP2).

Case presentation: An 80-year-old Japanese man was referred for sustained ventricular tachycardia. His baseline electrocardiogram showed negative T waves in V1-V4. Right ventriculography showed right ventricular aneurysm. Because this case met three major criteria, ARVC was diagnosed. He was successfully treated with radiofrequency ablation and oral amiodarone. Genetic analysis identified an insertion mutation in exon 8 of PKP2 (1725_1728dupGATG), which caused a frameshift and premature termination of translation (R577DfsX5).

Conclusions: To the best of our knowledge, this is the first report of newly diagnosed ARVC in an octogenarian associated with a loss-of-function PKP2 pathogenic variant. Although the late clinical presentation of ARVC is rare, it should be included in the differential diagnosis when treating older patients with ventricular tachyarrhythmias.

Keywords: Arrhythmogenic right ventricular cardiomyopathy; Elderly; Octogenarian; Plakophilin 2.

Publication types

  • Case Reports
  • Video-Audio Media

MeSH terms

  • Aged, 80 and over
  • Amiodarone / administration & dosage
  • Anti-Arrhythmia Agents / administration & dosage
  • Arrhythmogenic Right Ventricular Dysplasia / diagnosis
  • Arrhythmogenic Right Ventricular Dysplasia / genetics*
  • Arrhythmogenic Right Ventricular Dysplasia / physiopathology
  • Arrhythmogenic Right Ventricular Dysplasia / therapy
  • Catheter Ablation
  • Genetic Predisposition to Disease
  • Humans
  • Loss of Function Mutation*
  • Male
  • Phenotype
  • Plakophilins / genetics*
  • Risk Factors
  • Treatment Outcome

Substances

  • Anti-Arrhythmia Agents
  • PKP2 protein, human
  • Plakophilins
  • Amiodarone